{"nct_id":"NCT00968968","title":"Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone","status":"TERMINATED","status_verified_date":"2019-06","start_date":"2010-01-20","start_date_type":"ACTUAL","primary_completion_date":"2014-02-21","primary_completion_date_type":"ACTUAL","completion_date":"2018-03-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}